论文部分内容阅读
目的 :比较弥可保和维生素B12 (VB12 )治疗周围性面瘫 (PFP)的疗效。方法 :以 30例弥可保治疗患者及 39例VB12 治疗患者为研究对象 ,在治疗前后分别按改良Portmann评分法 (RPA)计算积分 ,用面神经电图(ENoG)检测潜伏期及波幅 ,并计算患健侧比例。结果 :每组患者治疗前后及治疗后二组间的RPA积分及患健侧潜伏期比例有统计学上的差异。结论 :弥可保及VB12 治疗PFP均有明显的疗效 ,但前者的疗效更明显
Objective: To compare the efficacy of Mi-Pak and vitamin B12 (VB12) in the treatment of peripheral facial paralysis (PFP). Methods: Thirty patients treated with methycobal and 39 patients treated with VB12 were enrolled in the study. Before and after treatment, integrals were calculated according to modified Portmann score (RPA), and latency and amplitude were detected by facial nerve electrogram (ENoG) Contralateral ratio. Results: There was a statistically significant difference in RPA score and contralateral latency between the two groups before and after treatment and after treatment. Conclusion: Both Mifeprist and VB12 have obvious curative effect on PFP, but the effect of the former is more obvious